Clinical Trial Update: Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring best practices for rocuronium reversal with neostigmine or sugammadex in patients with muscle weakness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Weakness

Drugs mentioned

• Neostigmine (neostigmine)
• Rocuronium (rocuronium bromide)
• Sugammadex (sugammadex)

Snippet

Sponsor: University of Washington | Conditions: Muscle Weakness | Phase 4 | Status: COMPLETED | Results posted: 2022-11-09